Page last updated: 2024-09-04

zosuquidar trihydrochloride and nelfinavir

zosuquidar trihydrochloride has been researched along with nelfinavir in 1 studies

Compound Research Comparison

Studies
(zosuquidar trihydrochloride)
Trials
(zosuquidar trihydrochloride)
Recent Studies (post-2010)
(zosuquidar trihydrochloride)
Studies
(nelfinavir)
Trials
(nelfinavir)
Recent Studies (post-2010) (nelfinavir)
6011,240230240

Protein Interaction Comparison

ProteinTaxonomyzosuquidar trihydrochloride (IC50)nelfinavir (IC50)
Tyrosine-protein kinase FynHomo sapiens (human)7.971
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)8.852
ATP-dependent translocase ABCB1Homo sapiens (human)3.3938
Cytochrome P450 3A4Homo sapiens (human)1.275
ATP-dependent translocase ABCB1Mus musculus (house mouse)2.3
Sodium-dependent noradrenaline transporter Homo sapiens (human)8.852
Protease Human immunodeficiency virus 10.53
Protease Human immunodeficiency virus 10.0054

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choo, EF; Imamura, H; Kim, RB; Leake, B; Wandel, C; Wilkinson, GR; Wood, AJ1

Other Studies

1 other study(ies) available for zosuquidar trihydrochloride and nelfinavir

ArticleYear
Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes.
    Drug metabolism and disposition: the biological fate of chemicals, 2000, Volume: 28, Issue:6

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Brain; Caco-2 Cells; Dibenzocycloheptenes; HIV Protease Inhibitors; Humans; Inhibitory Concentration 50; Male; Mice; Quinolines; Testis

2000